101 related articles for article (PubMed ID: 27251913)
1. The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem?
Muls AC; Lalji A; Marshall C; Butler L; Shaw C; Vyoral S; Mohammed K; Andreyev HJ
Clin Med (Lond); 2016 Jun; 16(3):240-6. PubMed ID: 27251913
[TBL] [Abstract][Full Text] [Related]
2. A proposed tailored investigational algorithm for women treated for gynaecological cancer with long-term gastrointestinal consequences.
Muls A; Taylor A; Lalondrelle S; Kabir M; Norton C; Hart A; Andreyev HJ
Support Care Cancer; 2020 Oct; 28(10):4881-4889. PubMed ID: 31997018
[TBL] [Abstract][Full Text] [Related]
3. Clinical decision-making in managing changes in gastrointestinal function following cancer therapies: Is experience enough?
Muls AC; Klimova K; Andreyev HJN
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28892252
[TBL] [Abstract][Full Text] [Related]
4. Acta Oncologica Lecture. Gastrointestinal consequences of cancer treatment and the wider context: a bad gut feeling.
Muls AC
Acta Oncol; 2014 Mar; 53(3):297-306. PubMed ID: 24460087
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal consequences of cancer treatment: evaluation of 10 years' experience at a tertiary UK centre.
Gadhok R; Paulon E; Tai C; Olushola T; Barragry J; Rahman F; Di Caro S; Mehta S
Frontline Gastroenterol; 2021; 12(6):471-477. PubMed ID: 34712464
[TBL] [Abstract][Full Text] [Related]
6. Outcomes from treating bile acid malabsorption using a multidisciplinary approach.
Gupta A; Muls AC; Lalji A; Thomas K; Watson L; Shaw C; Andreyev HJ
Support Care Cancer; 2015 Oct; 23(10):2881-90. PubMed ID: 25693765
[TBL] [Abstract][Full Text] [Related]
7. Probiotic use in clinical practice: Results of a national survey of gastroenterologists and nutritionists.
Valdovinos-García LR; Abreu AT; Valdovinos-Díaz MA
Rev Gastroenterol Mex (Engl Ed); 2019; 84(3):303-309. PubMed ID: 31383293
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.
Wedlake L; Thomas K; Lalji A; Anagnostopoulos C; Andreyev HJ
Clin Ther; 2009 Nov; 31(11):2549-58. PubMed ID: 20109999
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of bowel problems reported in a palliative care population.
Clark K; Smith JM; Currow DC
J Pain Symptom Manage; 2012 Jun; 43(6):993-1000. PubMed ID: 22651945
[TBL] [Abstract][Full Text] [Related]
10. The significance of rectal bleeding after pelvic radiotherapy.
Williams HR; Vlavianos P; Blake P; Dearnaley DP; Tait D; Andreyev HJ
Aliment Pharmacol Ther; 2005 May; 21(9):1085-90. PubMed ID: 15854169
[TBL] [Abstract][Full Text] [Related]
11. Is "pelvic radiation disease" always the cause of bowel symptoms following prostate cancer intensity-modulated radiotherapy?
Min M; Chua B; Guttner Y; Abraham N; Aherne NJ; Hoffmann M; McKay MJ; Shakespeare TP
Radiother Oncol; 2014 Feb; 110(2):278-83. PubMed ID: 24412017
[TBL] [Abstract][Full Text] [Related]
12. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study.
Wedlake L; Thomas K; McGough C; Andreyev HJ
Eur J Cancer; 2008 Oct; 44(15):2212-7. PubMed ID: 18760593
[TBL] [Abstract][Full Text] [Related]
13. A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy.
Olopade FA; Norman A; Blake P; Dearnaley DP; Harrington KJ; Khoo V; Tait D; Hackett C; Andreyev HJ
Br J Cancer; 2005 May; 92(9):1663-70. PubMed ID: 15856043
[TBL] [Abstract][Full Text] [Related]
14. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy.
Henson CC; Burden S; Davidson SE; Lal S
Cochrane Database Syst Rev; 2013 Nov; (11):CD009896. PubMed ID: 24282062
[TBL] [Abstract][Full Text] [Related]
15. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?
Andreyev HJ; Vlavianos P; Blake P; Dearnaley D; Norman AR; Tait D
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1464-71. PubMed ID: 15927411
[TBL] [Abstract][Full Text] [Related]
17. Prospective Study of Malabsorption and Malnutrition After Esophageal and Gastric Cancer Surgery.
Heneghan HM; Zaborowski A; Fanning M; McHugh A; Doyle S; Moore J; Ravi N; Reynolds JV
Ann Surg; 2015 Nov; 262(5):803-7; discussion 807-8. PubMed ID: 26583669
[TBL] [Abstract][Full Text] [Related]
18. Patients with inflammatory bowel disease and their treating clinicians have different views regarding diet.
Holt DQ; Strauss BJ; Moore GT
J Hum Nutr Diet; 2017 Feb; 30(1):66-72. PubMed ID: 27412965
[TBL] [Abstract][Full Text] [Related]
19. Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study.
Strasser F; Sweeney C; Willey J; Benisch-Tolley S; Palmer JL; Bruera E
J Pain Symptom Manage; 2004 Jun; 27(6):481-91. PubMed ID: 15165646
[TBL] [Abstract][Full Text] [Related]
20. 'Be Clear on Cancer': the impact of the UK National Bowel Cancer Awareness Campaign.
Peacock O; Clayton S; Atkinson F; Tierney GM; Lund JN
Colorectal Dis; 2013 Aug; 15(8):963-7. PubMed ID: 23656572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
